治疗双J支架综合征的比较方法:单疗法还是组合疗法?
Cătălin Pricop1,2, Carina Alexandra Bandac2, Marius Ivanuță1,2
1"Grigore T Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.
Journal of clinical medicine
|July 27, 2024
概括
结合索利菲纳辛和坦苏洛辛的联合治疗有效地减少了双J尿路支架的症状,改善了患者的生活质量. 这种组合显示出对管理支架相关的不适和尿道问题有希望.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 药理学 药理学是指药理学的学科.
- 患者生活质量研究研究
背景情况:
- 双J尿管支架广泛使用,但会导致患者显著的症状和降低生活质量 (QoL).
- 现有的治疗支架相关症状的药物缺乏有效性的一致证据.
- 尿道支架症状问卷 (USSQ) 是一个验证的工具,用于评估支架相关的发病率.
研究的目的:
- 评估tamsulosin,solifenacin,mirabegron,desloratadine和组合疗法的有效性,以控制双J支架的症状.
- 将这些干预措施的有效性与安慰剂对照组进行比较.
- 确定最佳的药理方法,以改善尿管支架时患者的QOL.
主要方法:
- 一项前性随机试验,涉及327名患者进行首次双J支架插入.
- 患者被分配到六个组:对照组,坦苏洛辛,米拉贝格朗,索利费纳辛,德斯洛拉塔丁或组合治疗.
- 适应罗马尼亚的USSQ在基线和支架插入后30天进行了管理,以评估症状严重程度.
主要成果:
- 与对照组相比,药物组显示症状显著减少.
- 10毫克索利费纳和0.4毫克坦苏洛辛的组合证明了统计学上显著的疼痛减轻 (p=0.001).
- 米拉贝格朗 (每天50毫克) 显示出尿路症状严重程度得分最低,对患者的工作影响最显著.
结论:
- 没有单一的药物是最终的解决方案,但索利费纳辛和坦苏洛辛的联合治疗是最有前途的缓解症状.
- 这种联合疗法显著改善了双J支架患者的症状和生活质量.
- 需要进一步进行广泛的研究来证实这些发现,并制定最终的治疗指南.
更多相关视频
06:26Novel and Innovative Hybrid Technique for Type A Aortic Dissection
Published on: March 28, 2025
222
13:48Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
Published on: April 21, 2023
1.4K
相关概念视频
01:27Combined Effects of Drugs: Synergism
3.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.8K
01:26Peptic Ulcer Disease IV: Management
79
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
79
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
505
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
505
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
481
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
481
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
413
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
413